Email updates

Keep up to date with the latest news and content from Italian Journal of Pediatrics and BioMed Central.

Open Access Letter to the Editor

The R156H variation in IL-12Rβ1 is not a mutation

Esther van de Vosse1*, Jaap T van Dissel1, Loredana Palamaro2, Giuliana Giardino2, Francesca Santamaria2, Rosa Romano2, Anna Fusco2, Silvia Montella2, Mariacarolina Salerno2, Matilde Valeria Ursini3 and Claudio Pignata2*

Author Affiliations

1 Department of Infectious Diseases, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands

2 Department of Translational Medical Sciences, “Federico II” University, Naples, Italy

3 International Institute of Genetics and Biophysics, CNR, Naples, Italy

For all author emails, please log on.

Italian Journal of Pediatrics 2013, 39:12  doi:10.1186/1824-7288-39-12

Published: 14 February 2013


Palamaro et al. describe a child with recurrent bronchopneumonia and very high IgE levels in which a variation, R156H, was found in the IL12RB1 gene that encodes the IL-12Rβ1 chain. Based on the absence of this variation in 50 unrelated individuals they conclude it is a mutation. We (van de Vosse and van Dissel) feel there is no reason to suspect a defect in IL-12 signaling based on the clinical data, nor evidence for a functional defect in IL-12 signaling in this patient. In addition, the variation is not novel and known as a polymorphism. Without any functional evidence that R156H is a mutation, the current claim is not substantiated.

Palamaro et al. respond to argue that the amino acid substitution, R156H described in the described case exerts a summatory effect, as a genetic cofactor, along with an additional and still unidentified molecular alteration of the same pathway.

IL12RB1; IL-12Rβ1; Immunodeficiency; Mutation; Mycobacterial disease